These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11923062)

  • 41. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
    Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of extended dwell time during pre- and main compression on the properties of ibuprofen tablets.
    Peeters E; Silva AFT; Fonteyne M; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2018 Jul; 128():300-315. PubMed ID: 29733949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):175-80. PubMed ID: 16462059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SeDeM expert system a new innovator tool to develop pharmaceutical forms.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Miñarro M; Ticó JR
    Drug Dev Ind Pharm; 2014 Feb; 40(2):222-36. PubMed ID: 23343308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone.
    Shu T; Suzuki H; Hironaka K; Ito K
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):193-8. PubMed ID: 11848208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
    AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
    Abbaspour MR; Sadeghi F; Garekani HA
    Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients.
    Comoglu T; Dogan A; Comoglu S; Basci N
    Drug Dev Ind Pharm; 2011 Mar; 37(3):260-7. PubMed ID: 20704458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets.
    Pabari R; Ramtoola Z
    J Young Pharm; 2012 Jul; 4(3):157-63. PubMed ID: 23112534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.